Western Blot (WB)
((Figure. Western Blot; Sample: Recombinant protein.))
Guinea Pig anti-Rabbit Insulin Like Growth Factor 2 Polyclonal Antibody | anti-IGF2 antibody
Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2)
Reactivity
Rabbit
Applications
Western Blot, Immunocytochemistry, Immunohistochemistry, ELISA
Purity
Affinity Chromatography
Synonyms
Insulin Like Growth Factor 2; Polyclonal Antibody; Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2); anti-IGF2 antibody
Host
Guinea Pig
Reactivity
Rabbit
Clonality
Polyclonal
Specificity
The antibody is a cavia polyclonal antibody raised against IGF2. It has beenselected for its ability to recognize IGF2 in immunohistochemical staining andwestern blotting.
Purity/Purification
Affinity Chromatography
Concentration
500ug/mL (varies by lot)
Applicable Applications for anti-IGF2 antibody
Western Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (EIA)
Fragment
IGF2 (Ala25~Lys181)
Organism Species
Oryctolagus cuniculus (Rabbit)
Cross Reactivity
Rabbit
Conjugate
No Conjugate
Immunogen
Recombinant IGF2 (Ala25~Lys181) expressed in E Coli.
Preparation and Storage
Store at 4 degree C for frequent use. Stored at -20 degree C to -80 degree C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Western Blot (WB)
((Figure. Western Blot; Sample: Recombinant protein.))
Western Blot (WB)
((Figure. Western Blot; Sample: Recombinant protein.))
Similar Products
Product Notes
The IGF2 (Catalog #AAA2027532) is an Antibody produced from Guinea Pig and is intended for research purposes only. The product is available for immediate purchase. The Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2) reacts with Rabbit and may cross-react with other species as described in the data sheet. AAA Biotech's Insulin Like Growth Factor 2 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (EIA). Researchers should empirically determine the suitability of the IGF2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "Insulin Like Growth Factor 2, Polyclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
